Canada’s political turmoil - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
FT商学院

Canada’s political turmoil

Trump’s tariff threat has helped to precipitate a leadership crisis

After France and Germany, Canada has become the third big economy to plunge into political turmoil weeks before Donald Trump’s return as US president. Finance minister Chrystia Freeland’s stunning resignation on Monday after falling out with Justin Trudeau has prompted calls for the prime minister himself to stand down — including from within his own Liberal party. Having leadership crises in three G7 democracies just when US allies must work together to deal with a new disruptive president in the White House is unfortunate. For Canada, the timing is especially poor. The crisis was precipitated in part by Trump’s threat of 25 per cent tariffs on Canadian imports, which could severely damage its economy.

The trigger for Freeland’s departure was Trudeau’s attempt to demote her last Friday, having reportedly courted Mark Carney, former central bank governor in Canada and the UK, to replace her. The finance minister and prime minister had been at loggerheads over the government’s plan for a wide-ranging exemption to Canada’s goods and services tax and a C$250 ($175) cheque for nearly half the country’s population. Critics have decried these steps as an effort to buy votes by a government trailing badly in the polls before elections due by next October, at the cost of a soaring budget deficit.

Freeland’s scathing resignation letter referred to “costly political gimmicks”, insisting Canada must keep its “fiscal powder dry” ahead of a potential tariff war with Trump’s US. The outgoing finance minister commendably presented herself as a guardian of fiscal responsibility, though she cannot escape association with the policies that have laid the cabinet low.

The nine-year-old government has fallen far from its onetime political grace, running 20 points behind right-leaning Conservative leader Pierre Poilievre. Like centre-left parties elsewhere, Trudeau’s government has struggled to address discontent over spiralling living and housing costs, and immigration. A country that was long welcoming to newcomers began to chafe at the ambitious immigration targets on which the Liberal-led administration relied to boost sluggish growth — opening the way for the anti-elite populist Poilievre. A government once seen as embodying hopes for a renewal of liberalism in western democracies has not been helped by what many now see as Trudeau’s sanctimonious style.

Freeland’s exit, on the day another capable minister said he would stand down at the next election, suggests the prime minister has lost his government’s trust. Trudeau has said he will consider his position over the holidays. In reality, his party’s decline is highly unlikely to be reversed while he remains leader. Trudeau may believe he is best-placed to deal with Trump’s threat of tariffs on close to 80 per cent of Canada’s exports, given the relationship he built up during the president’s first term. But the returning US leader has been openly trolling him as the “governor” of the “Great State of Canada”.

Trudeau should consider whether his continued leadership is in the country’s best interests. A new leader and fresh programme might yet be able to cap the Liberals’ election losses and limit the Conservatives to a minority — forcing them to govern with partners and potentially restraining a Canadian tilt to the populist right.

The crisis in Canada highlights how Trump’s return is already upturning politics in US allies even before he is inside the White House. It demonstrates once again the need for parties of the centre-left and centre-right to find better ways to counter the rise of would-be Trumps elsewhere. For Canada’s liberal standard bearer, however, the best way to safeguard his political legacy is to hand over to someone else.

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

肺纤维化生物科技公司Avalyn Pharma申请首次公开募股(IPO)

一家生物技术公司正开发可吸入剂型的已获批肺纤维化口服药,计划赴公开市场融资以支持其后期研发。
5小时前

凯勒拉治疗学公司在生物技术领域创纪录的IPO中融资6.25亿美元

最新的生物科技公司首次公开募股创下历史新高。
19小时前

法国将迎来最拥挤的大选角逐场:谁将取代马克龙?

左翼和中间阵营的分裂,助长了极右翼问鼎爱丽舍宫的希望。

全球失衡的凯恩斯式解决方案

自20世纪40年代以来,经济学家一直在提出各种方案,试图修复由国际储备货币所造成的结构性问题。

伊朗战争在多大程度上影响美国通货膨胀?

日元接下来何去何从?英国今年的经济增长是否正在回升?

华尔街顶级律师事务所如何沦为内幕交易的输送渠道

并购咨询已演变成庞大的法律业务,却让律所在机密信息被滥用方面更加脆弱。
设置字号×
最小
较小
默认
较大
最大
分享×